An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone on Reddit asked whether to stop using two "nootropic" peptides, Selank and Semax, now that they're starting a prescription drug called atomoxetine. They'd already bought the peptides and want to know if they should finish the course or pause them while trying the new medication, because they don't want other substances to cloud their experience or waste money. Atomoxetine is a prescription medication used mainly for attention-deficit/hyperactivity disorder (ADHD). It works differently than stimulants like amphetamines; it increases levels of noradrenaline (a brain chemical linked to attention and alertness). Selank and Semax are short peptides developed in Russia and often sold as cognitive enhancers. People who use them believe they can improve focus, reduce anxiety, or help mood, but they're not approved as drugs in many countries and are usually sold as research chemicals or supplements. The evidence here is mostly a mixture of small studies, animal work, and lots of anecdote. Atomoxetine has clinical trial data showing it can help ADHD symptoms in many people. Selank and Semax have some preclinical and small human studies suggesting effects on anxiety, memory, or stress responses, but the research is limited and not robust by modern regulatory standards. There’s little formal research on how these peptides interact with prescription drugs like atomoxetine. So the question of whether they would interfere with the medication, amplify side effects, or change how you feel is largely unanswered by high-quality studies. Why this matters is practical: if someone wants to judge whether atomoxetine is helping or causing side effects, adding other active substances at the same time makes it hard to know what’s doing what. That matters when you and your doctor make decisions about dose, continuation, or switching treatments. It also matters financially—if the peptides are expensive, you might not want to finish them if they could blur the picture. For people trying a new prescription for the first time, keeping other potential cognitive enhancers out of the mix helps get a clear read on the medication’s effects. There are important cautions. Prescription drugs like atomoxetine should be managed with a doctor’s guidance. Combining unregulated peptides with prescription medications can carry unknown risks: they might increase side effects like increased heart rate, blood pressure changes, anxiety, or other problems, or they might do nothing but still complicate your experience. The regulatory status and quality control of Selank and Semax can vary, so purity and dosing are uncertain. If you’re unsure, the safest option is to discuss it with the prescriber and consider pausing the peptides while you assess atomoxetine, or at least stop them during the initial trial period when dose adjustments are common. Bottom line: to get a clear sense of whether atomoxetine works and to avoid unknown interactions, it’s reasonable to set the peptides aside while you try the new medication and discuss the plan with your doctor.
Source: r/Nootropics